Koers Tobira Therapeutics Inc Nasdaq
Aandelen
US75874Q1076
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | - |
Scott Reents
DFI | Director of Finance/CFO | 57 | - |
Corporate Secretary | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,47% | 122 mld. | |
+19,47% | 115 mld. | |
+21,22% | 26,64 mld. | |
-23,54% | 19,91 mld. | |
-17,47% | 16,32 mld. | |
-45,95% | 15,52 mld. | |
-18,60% | 15,49 mld. | |
+62,28% | 14,83 mld. | |
+1,98% | 13,67 mld. |